We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
Topical steroid products are safe and highly effective treatments for the management of a wide range of inflammatory skin diseases but have important risks, especially with prolonged use at high potency. In the coming months, as a result of regulatory...
Product Safety Report for GDK Akagni Skin Toning Cream presenting a serious chemical risk.
Covering thalidomide, lenalidomide, and pomalidomide: temporary guidance for pregnancy prevention arrangements for patients taking them during COVID-19
This guidance (HPA-CRCE-044) gives a procedure for monitoring of the thyroid using mini instruments type 44 and type 42 probes.
Get help to classify herbal medicines, vitamins, food preparations, supplements and tonics for import and export.
MHRA review of levothyroxine products in response to concerns about potential inconsistencies of different products.
Reported problems with the supply of an animal medicine and the date when the issue is expected to be resolved.
How to apply for a traditional herbal registration (THR) to market a herbal medicine in the UK.
Details of the suspension of the marketing authorisation of Levothyroxine 100 microgram tablets, including MHRA investigations.
The CMA investigated alleged excessive and unfair pricing with respect to liothyronine tablets under Chapter II CA98.
You must tell DVLA if you have a pituitary tumour - download the correct form to let them know
Information on herbal medicines, how to apply for a traditional herbal registration (THR), banned or restricted herbal ingredients, homeopathic medicines and fees.
Information for healthcare professionals on diphtheria anti-toxin (DAT).
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).